A Granulocyte-Specific Protein S100A12 as a Potential Prognostic Factor Affecting Aggressiveness of Therapy in Patients with Juvenile Idiopathic Arthritis.

Conclusions: S100A12 may become an important factor influencing decisions on aggressiveness of JIA therapy. Further elaboration on the clinical algorithm is necessary for that protein to be included in everyday practice. PMID: 30426025 [PubMed - in process] (Source: Journal of Immunology Research)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2DoQS3s